drugset / Trial / NCT00144014
Safety and Efficacy Study in Acute Ischaemic Stroke
Non-randomizedParallel-groupOpen-labelTreatment
Summary
A Phase II study to evaluate the safety and efficacy of five dose levels of study drug in acute ischaemic stroke
Timeline
- Start
- 2005-08
- Primary completion
- 2008-11
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Troplasminogen alfa | Unknown | 1 mg/kg | Intravenous |
| Subject | Troplasminogen alfa | Unknown | 2.5 mg/kg | Intravenous |
| Subject | Troplasminogen alfa | Unknown | 5 mg/kg | Intravenous |
| Subject | Troplasminogen alfa | Unknown | 7.5 mg/kg | Intravenous |
| Subject | Troplasminogen alfa | Unknown | 10 mg/kg | Intravenous |